Published in Haematologica on May 26, 2017
DNA methylation age of human tissues and cell types. Genome Biol (2013) 7.48
Graft-versus-leukemia reactions after bone marrow transplantation. Blood (1990) 7.11
Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet (1998) 2.87
DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol (2015) 2.51
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach. Nat Rev Clin Oncol (2012) 2.05
In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci U S A (1997) 1.58
Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. Biol Blood Marrow Transplant (2007) 1.47
Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood (2001) 1.26
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood (2015) 1.09
Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort. Clin Epigenetics (2016) 1.05
Epigenetic aging upon allogeneic transplantation: the hematopoietic niche does not affect age-associated DNA methylation. Leukemia (2014) 1.02
Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss. Blood (2002) 0.91
Epigenetic clock analyses of cellular senescence and ageing. Oncotarget (2016) 0.90
Telomere shortening in leucocyte subsets of long-term survivors of allogeneic bone marrow transplantation. Br J Haematol (1999) 0.84
Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy. Br J Haematol (2003) 0.83